HHS Secretary Robert F. Kennedy Jr, is a well-known vaccine critic, but it is way past time for human health to be put on a ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

KNOWING where to invest your cash is difficult as there are thousands of companies to choose from. That’s why Holly Mead, a ...

In addition to Barclays, Sanofi also received a Buy from J.P. Morgan’s Richard Vosser in a report issued on August 8. However, on August 5, Deutsche Bank maintained a Hold rating on Sanofi (Other OTC: ...

Indian equities fell on August 12, with the Nifty 50 down 0.40% and the S&P BSE Sensex down 0.46%. Investors were cautious ahead of US inflation data, which could influence the Federal Reserve's ...

Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...

While all three acknowledge a strong first quarter for the financial year 2026, they differ in their long-term views.Morgan ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

A powerful wave of optimism continued to wash over global markets on Wednesday, propelling European equities higher as ...

PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC)Spero ...

The ADC market is rapidly advancing due to next-gen oncology therapeutics and increased R&D, offering significant opportunities for addressing treatment-resistant cancersDublin, Aug. 13, 2025 (GLOBE ...